Show simple item record

dc.contributor.advisorTalukder, Mesbah
dc.contributor.authorBhuiyan, Tanjina Pioush
dc.date.accessioned2025-01-13T05:03:18Z
dc.date.available2025-01-13T05:03:18Z
dc.date.copyright©2023
dc.date.copyright2023
dc.date.issued2023-04
dc.identifier.otherID 18346030
dc.identifier.urihttp://hdl.handle.net/10361/25135
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.en_US
dc.descriptionCataloged from PDF version of thesis.
dc.descriptionIncludes bibliographical references (pages 41-43).
dc.description.abstractMinoxidil, mostly used as a vasodilator was first introduced as an oral drug used to treat high blood pressure. Then gradually minoxidil showed hair darkening of fine body hair as a side effect. This specific side effect led to the development of topical minoxidil. Topical minoxidil is mainly produced as a 2% solution to treat female adrenergic alopecia and a 5% solution for male adrenergic alopecia. But the changes disappeared after stopping its use for a month. Minoxidil is mainly potassium channel opener so it assumes that it causes hyperpolarization and again it's a vasodilator. The mechanism it mainly widening blood vessels and opening potassium channels so it allows more oxygen and nutrients to the hair which causes regrowth of hair. This article will show a complete review of the pharmacokinetics, pharmacodynamics, and mechanism of action, side effects, and clinical efficacy of topical minoxidil.en_US
dc.description.statementofresponsibilityTanjina Pioush Bhuiyan
dc.format.extent43 pages
dc.language.isoenen_US
dc.publisherBRAC Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission
dc.subjectTopical minoxidilen_US
dc.subjectAdrenergic alopeciaen_US
dc.subjectHyperpolarizationen_US
dc.subjectVasodilatoren_US
dc.subjectDihydrotestosteroneen_US
dc.subject.lcshMinoxidil--Therapeutic Use.
dc.subject.lcshAndrogenetic Alopecia.
dc.subject.lcshClinical Trials--Hair Loss Treatments.
dc.titleA study on the efficacy of 2% and 5% topical minoxidil solution on Adrenergic Alopeciaen_US
dc.typeThesisen_US
dc.contributor.departmentSchool of Pharmacy, Brac University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record